ARCUS BIOSCIENCES INC (RCUS) Institutional Ownership and Insiders Activity
ARCUS BIOSCIENCES INC (RCUS) is widely held by institutional investors, with 238 firms reporting positions valued at approximately $3.18B based on SEC Form 13F filings for the quarter ended September 30, 2026.
Gilead Sciences, Inc. is the largest disclosed holder, reporting approximately $811.70M in RCUS holdings in its latest filing.
Recent insider activity includes 1 tracked Form 4 transaction over the last three months, reflecting ongoing executive and director trading activity.
Institutional Holders
238
Total Reported Value
$3.18B
Largest Holder
Gilead Sciences, Inc.
Largest Position
$811.70M
Insider Transactions (90d)
1
Latest Filing Quarter
Q3 2026
New Institutional Positions
45
Funds Exiting Positions
29
Top Institutional Owners
View allInvestorReported Balance
- Gilead Sciences, Inc.$811.70M
- Blackrock, Inc.$434.58M
- Wellington Management Group Llp$159.35M
- State Street Corp$143.88M
- Vanguard Portfolio Management Llc$114.70M
RCUS News
All news- Gilead Sciences Portfolio Concentration: Heavy Healthcare Exposure
Aug 4, 2026 · valut.ai
Related RCUS Institutional Insights:
- RCUS 13F Institutional Holders
- RCUS Superinvestors
- RCUS Institutional Ownership Changes
- Healthcare Sector Institutional Ownership
- Healthcare Sector Portfolio Overlap
- Institutional Portfolio Overlap & Shared Holdings
- Most Bought Healthcare Stocks By Institutional Investors
- Most Sold Healthcare Stocks By Institutional Investors
- RCUS Insider Trading & SEC Form 4 Activity
- RCUS Articles
- Top Institutional Investor Stock Rankings